BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3180020)

  • 1. A cytogenetic and molecular analysis of five variant Philadelphia translocations in chronic myeloid leukemia.
    Morris CM; Rosman I; Archer SA; Cochrane JM; Fitzgerald PH
    Cancer Genet Cytogenet; 1988 Oct; 35(2):179-97. PubMed ID: 3180020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
    Abe S; Minamihisamatsu M; Ishihara T; Sasaki M
    Cancer Genet Cytogenet; 1989 Mar; 38(1):61-74. PubMed ID: 2713815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations.
    Zaccaria A; Testoni N; Tassinari A; Celso B; Rassool F; Saglio G; Guerrasio A; Rosti G; Tura S
    Cancer Genet Cytogenet; 1989 Oct; 42(2):191-201. PubMed ID: 2790754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genesis of variant Philadelphia chromosome translocations in chronic myelocytic leukemia.
    Naumann S; Decker HJ
    Cancer Genet Cytogenet; 2003 Nov; 147(1):18-22. PubMed ID: 14580766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia.
    Morel F; Herry A; Le Bris MJ; Morice P; Bouquard P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2003 Dec; 147(2):115-20. PubMed ID: 14623460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
    Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
    Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transposition of breakpoint cluster region (3' bcr) in CML cells with variant Philadelphia translocations.
    Ohyashiki K; Ohyashiki JH; Kinniburgh AJ; Rowe J; Miller KB; Raza A; Preisler HD; Sandberg AA
    Cancer Genet Cytogenet; 1987 May; 26(1):105-15. PubMed ID: 3030534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
    Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation t(9;9)(p13;q34) in Philadelphia-negative chronic myeloid leukemia with breakpoint cluster region rearrangement.
    Sessarego M; Mareni C; Vimercati R; Defferrari R; Origone P; Damasio E; Ajmar F
    Cancer Genet Cytogenet; 1989 Nov; 43(1):51-6. PubMed ID: 2790772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly complex genetic rearrangement involving at least seven breakpoints in a case of chronic myeloid leukemia.
    Weinstein M; Grossman A; Dittmar K; Weiss R; Benn P
    Cancer Genet Cytogenet; 1990 Aug; 48(1):75-81. PubMed ID: 2164879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia.
    Zhang J; Meltzer P; Jenkins R; Guan XY; Trent J
    Blood; 1993 Jun; 81(12):3365-71. PubMed ID: 8507874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemia.
    Price CM; Rassool F; Shivji MK; Gow J; Tew CJ; Haworth C; Goldman JM; Wiedemann LM
    Blood; 1988 Nov; 72(5):1829-32. PubMed ID: 3179449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster region.
    Rassool F; Foroni L; Rahemtulla A; Dreazen O; Wiedemann L; Guo AP; Legon S; Catovsky D; Luzzatto L; Goldman J
    Cancer Genet Cytogenet; 1988 Jun; 32(2):217-27. PubMed ID: 3259155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
    Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
    Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakpoint cluster region rearrangements in chronic myelogenous leukemia with a masked Philadelphia chromosome.
    Ohyashiki JH; Ohyashiki K; Kinniburgh AJ; Raza A; Preisler HD; Sandberg AA
    Cancer Genet Cytogenet; 1987 Mar; 25(1):15-20. PubMed ID: 3026611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia.
    La Starza R; Testoni N; Lafage-Pochitaloff M; Ruggeri D; Ottaviani E; Perla G; Martelli MF; Marynen P; Mecucci C
    Haematologica; 2002 Feb; 87(2):143-7. PubMed ID: 11836164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive.
    Yehuda O; Abeliovich D; Ben-Neriah S; Sverdlin I; Cohen R; Varadi G; Orr R; Ashkenazi YJ; Heyd J; Lugassy G; Ben Yehuda D
    Cancer Genet Cytogenet; 1999 Oct; 114(2):100-7. PubMed ID: 10549264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.